CDK5R1: A Potential Drug Target and Biomarker for Tau Protein Kinase II 23 kDa Subunit

Target Name: CDK5R1

NCBI ID: G8851

CDK5R1

CDK5R1: A Potential Drug Target and Biomarker for Tau Protein Kinase II 23 kDa Subunit

Introduction

Tau protein kinase II 23 kDa subunit (CDK5R1) is a key regulator of microtubule dynamics and stability, which plays a crucial role in various cellular processes, including cell growth, differentiation, and autophagy. Tau mutations have been implicated in various neurological and psychiatric disorders , including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Therefore, targeting CDK5R1 to treat these disorders remains a major focus in research.

CDK5R1 functions as a protein kinase, which phosphates other proteins to activate or inactivate, thereby regulating life processes such as cell cycle, proliferation, differentiation and apoptosis. The phosphorylation of CDK5R1 involves a variety of proteins, including tubulin, intermediate fiber protein, nucleolar protein, etc. It plays a key role in cell division, cell cycle progression, and apoptosis. The phosphorylation status of CDK5R1 is closely related to the activity of proteins related to cell cycle execution. Therefore, studying the phosphorylation status of CDK5R1 is of great significance for understanding the cell cycle regulatory mechanism.

The phosphorylation status of CDK5R1 is closely related to neuronal survival and apoptosis. Neurons need to maintain stable cell cycle execution during their survival in order to carry out normal neuronal functions. However, when neurons are damaged or affected by certain diseases, cell cycle execution is disrupted, leading to neuronal death. Therefore, studying the role of CDK5R1 in neuronal survival and apoptosis provides new ideas for the treatment of neuronal diseases.

The phosphorylation status of CDK5R1 is also closely related to tumor occurrence and development. Many tumor cells have abnormal cell cycle execution, in which the phosphorylation status of CDK5R1 may be an important regulatory factor. Studies have found that the phosphorylation status of CDK5R1 is positively correlated with the growth, invasion and metastasis capabilities of tumor cells. Therefore, by regulating the phosphorylation status of CDK5R1, the growth and metastasis of tumor cells can be inhibited, providing a new means for tumor treatment.

The phosphorylation status of CDK5R1 is also closely related to neurodegenerative diseases. For example, the phosphorylation status of CDK5R1 is disrupted in the brains of patients with Alzheimer's disease and Parkinson's disease, leading to neuronal death and neurodegenerative diseases. Therefore, studying the role of CDK5R1 in neurodegenerative diseases provides new targets for the treatment of neurodegenerative diseases.

The phosphorylation status of CDK5R1 is also closely related to drug development. The mechanism of action of many anti-tumor drugs and anti-neurodegenerative drugs is through inhibiting the phosphorylation state of CDK5R1. For example, ipilimumab is an anti-tumor drug whose mechanism of action is to inhibit the growth of tumor cells by inhibiting the phosphorylation state of CDK5R1. Therefore, studying the phosphorylation status of CDK5R1 has important guiding significance for drug development.

The mechanism of action and biological significance of CDK5R1 have been extensively studied. However, the mechanism of action of CDK5R1 in drug targets still requires in-depth study. Despite this, more and more studies have found that CDK5R1 has important biological significance as a drug target, providing new ideas for drug development.

Conclusion

CDK5R1 is an important protein that plays a key role in cell cycle, proliferation, differentiation and apoptosis. The phosphorylation status of CDK5R1 is closely related to neuronal survival and apoptosis, tumor occurrence and development, neurodegenerative diseases, and drug development. Therefore, studying the biological significance of CDK5R1 is of great significance for understanding the cell cycle regulation mechanism, treating neuronal diseases and tumors, and delaying the development of neurodegenerative diseases. Future research should further study the mechanism of action of CDK5R1 in drug targets to provide new ideas for drug development.

Protein Name: Cyclin Dependent Kinase 5 Regulatory Subunit 1

Functions: p35 is a neuron specific activator of CDK5. The complex p35/CDK5 is required for neurite outgrowth and cortical lamination. Involved in dendritic spine morphogenesis by mediating the EFNA1-EPHA4 signaling. Activator of TPKII. The complex p35/CDK5 participates in the regulation of the circadian clock by modulating the function of CLOCK protein: phosphorylates CLOCK at 'Thr-451' and 'Thr-461' and regulates the transcriptional activity of the CLOCK-BMAL1 heterodimer in association with altered stability and subcellular distribution

The "CDK5R1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CDK5R1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets